Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phenotype variations in Gaucher disease.

P Mistry1, D P Germain

  • 1Yale University School of Medicine, Internal Medicine, New Haven, CT 06520, USA.

La Revue De Medecine Interne
|April 29, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expanded statistical analysis of squats on the Great Britain (GB) mainline network.

Heliyon·2023
Same author

Screening for Fabry disease in male patients with end-stage renal disease in western France.

Nephrologie & therapeutique·2021
Same author

Comparison of clinical and paraclinical characteristics of patients with urge, mixed, and passive fecal incontinence: a systematic literature review.

International journal of colorectal disease·2020
Same author

Assessing facial recognition after orthognathic surgery at automated border controls in airports.

The British journal of oral & maxillofacial surgery·2019
Same author

Changes in glycaemic control, blood pressure and lipids 5 years following laparoscopic adjustable gastric banding combined with medical care in patients with type 2 diabetes: a longitudinal analysis.

Clinical obesity·2018
Same author

Corrigendum to "An "all 5 mm ports" technique for laparoscopic day-case anti-reflux surgery: A consecutive case series of 205 patients" [Int. J. Surg. 35 (2016) 214-217].

International journal of surgery (London, England)·2017
Same journal

[Abdominal pain, fever and arthralgia in a 49-year-old woman].

La Revue de medecine interne·2026
Same journal

[Cardiorespiratory functional disorders: A transnosologic approach].

La Revue de medecine interne·2026
Same journal

[Diagnostic evaluation for suspected polycythemia].

La Revue de medecine interne·2026
Same journal

Heart involvements in systemic sclerosis beyond pulmonary hypertension: From conduction, rhythm and function defects to coronary artery disease.

La Revue de medecine interne·2026
Same journal

[Acute intermittent porphyria: When diagnostic errance jeopardizes patient health].

La Revue de medecine interne·2026
Same journal

Autosomal dominant polycystic kidney disease: Current perspectives in 2026.

La Revue de medecine interne·2026
See all related articles

Gaucher disease diagnosis requires analyzing all disease aspects, not just blood counts or spleen size. Biochemical and molecular testing, alongside genetic modifiers, helps predict disease severity and progression.

Area of Science:

  • Biochemistry
  • Genetics
  • Internal Medicine

Background:

  • Gaucher disease presents a complex phenotype not solely assessed by blood counts or splenomegaly.
  • Comprehensive analysis across all disease compartments is crucial for accurate evaluation.
  • The International Collaborative Gaucher Group registry offers valuable data for understanding disease natural history.

Purpose of the Study:

  • To highlight the complexity of Gaucher disease phenotypes.
  • To emphasize the importance of biochemical and molecular diagnostics.
  • To explore genotype-phenotype correlations and the role of genetic modifiers.

Main Methods:

  • Biochemical assay of glucocerebrosidase activity for diagnosis.
  • Molecular diagnosis to predict disease severity and progression.

Related Experiment Videos

  • Analysis of data from the International Collaborative Gaucher Group registry.
  • Main Results:

    • Biochemical assay is the most reliable diagnostic method for Gaucher disease.
    • Molecular diagnosis aids in predicting clinical manifestation severity and progression rate.
    • Genotype-phenotype correlations exhibit significant inter-individual variability, influenced by genetic modifiers.

    Conclusions:

    • Gaucher disease diagnosis and management require a holistic approach beyond simple clinical markers.
    • Biochemical and molecular diagnostics are essential tools for understanding and predicting disease course.
    • Further analysis of registry data is expected to enhance comprehension of Gaucher disease's natural history.